The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor.
Interleukin-1 (IL-1) is a major proinflammatory cytokine produced by monocytes/macrophages. At the inflammatory site, IL-1 is a potent inducer of the production of prostaglandin E2 (PGE2) and metalloproteinases on fibroblast-like cells, thus triggering tissue damage. The biological activity of IL-1...
Na minha lista:
| Publicado no: | J Clin Invest |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Clinical Investigation
1995
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC185170/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7615809/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI118045 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|